78.82
前日終値:
$81.52
開ける:
$81.15
24時間の取引高:
219.88K
Relative Volume:
1.12
時価総額:
$1.77B
収益:
$213.03M
当期純損益:
$41.32M
株価収益率:
43.07
EPS:
1.83
ネットキャッシュフロー:
$33.49M
1週間 パフォーマンス:
-4.45%
1か月 パフォーマンス:
-18.73%
6か月 パフォーマンス:
-12.12%
1年 パフォーマンス:
+18.33%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
LMAT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LMAT
Lemaitre Vascular Inc
|
78.82 | 1.77B | 213.03M | 41.32M | 33.49M | 1.83 |
![]()
ISRG
Intuitive Surgical Inc
|
476.78 | 170.05B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
222.79 | 63.97B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
86.81 | 42.94B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
219.72 | 32.28B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
34.55 | 17.64B | 17.28B | 108.00M | 391.00M | 0.20 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2025-02-28 | ダウングレード | Oppenheimer | Outperform → Perform |
2025-02-13 | 開始されました | Wells Fargo | Equal Weight |
2024-10-15 | 開始されました | Cantor Fitzgerald | Neutral |
2024-08-02 | 再開されました | Lake Street | Buy |
2024-05-31 | 再開されました | ROTH MKM | Buy |
2024-04-26 | アップグレード | Stifel | Hold → Buy |
2024-02-06 | 再開されました | KeyBanc Capital Markets | Sector Weight |
2023-10-23 | 開始されました | JMP Securities | Mkt Outperform |
2023-09-06 | 開始されました | Oppenheimer | Outperform |
2023-08-03 | ダウングレード | Jefferies | Buy → Hold |
2023-05-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2022-10-28 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2021-09-16 | 開始されました | Jefferies | Buy |
2021-02-12 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-03-16 | アップグレード | Sidoti | Neutral → Buy |
2019-10-24 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
2019-10-24 | アップグレード | Lake Street | Hold → Buy |
2019-10-14 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
2019-07-25 | 繰り返されました | Barrington Research | Outperform |
2019-07-25 | アップグレード | First Analysis Sec | Neutral → Outperform |
2018-10-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2018-10-08 | アップグレード | ROTH Capital | Neutral → Buy |
2018-06-08 | 再開されました | ROTH Capital | Buy |
2018-04-26 | ダウングレード | Stifel | Buy → Hold |
2018-04-26 | アップグレード | The Benchmark Company | Hold → Buy |
2017-10-27 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
2017-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
2017-07-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
2017-07-10 | ダウングレード | The Benchmark Company | Buy → Hold |
2017-03-21 | 開始されました | First Analysis Sec | Overweight |
2017-02-22 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2016-09-22 | ダウングレード | Sidoti | Buy → Neutral |
2016-07-28 | 繰り返されました | Barrington Research | Outperform |
2016-02-25 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Lemaitre Vascular Inc (LMAT) 最新ニュース
Down -15.37% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Nasdaq
Smartleaf Asset Management LLC Buys 293 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Bank of New York Mellon Corp Lowers Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $95.25 - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Will Pay A Larger Dividend Than Last Year At $0.20 - Yahoo Finance
LeMaitre Vascular's (NASDAQ:LMAT) Shareholders Will Receive A Bigger Dividend Than Last Year - Simply Wall St
Ex-Dividend Reminder: LeMaitre Vascular, Mercury General and CBL & Associates Properties - Nasdaq
(LMAT) Investment Analysis - Stock Traders Daily
Geneva Capital Management LLC Has $79.76 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Bahl & Gaynor Inc. Has $11.26 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Independent Director Lawrence Jasinski Sold A Bunch Of Shares In LeMaitre Vascular - Simply Wall St
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - Yahoo Finance UK
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
LeMaitre Vascular, Inc. to Host Earnings Call - ACCESS Newswire
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Dividend Increase$0.20 Per Share - MarketBeat
Q3 Earnings Estimate for LMAT Issued By Barrington Research - MarketBeat
LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know - MSN
Insider Sell: Lawrence Jasinski Sells Shares of LeMaitre Vascula - GuruFocus.com
LeMaitre Vascular director sells $289,064 in stock - Investing.com
LeMaitre Vascular director sells $289,064 in stock By Investing.com - Investing.com UK
3 Best Earnings Growth Stocks to Buy in March: CAKE, LMAT, HURN - Yahoo Finance
Sanctuary Advisors LLC Has $207,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
13,432 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Acquired by Illumine Investment Management LLC - MarketBeat
Principal Financial Group Inc. Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap DownHere's What Happened - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Lake Street Capital Analyst Says - MarketBeat
Best Momentum Stocks to Buy for March 4th - Nasdaq
Stentless Bioprostheses Market Is Booming Worldwide 2025-2032 - openPR
LeMaitre Vascular (NASDAQ:LMAT) Downgraded to "Market Perform" Rating by Oppenheimer - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Posts Quarterly Earnings Results, Hits Estimates - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2025 Earnings Guidance - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in March - GlobeNewswire
LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Cut to Market Perform at Barrington Research - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Cut to “Market Perform” at Barrington Research - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Cut to “Market Perform” at Oppenheimer - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $110.00 - Defense World
Truist Financial Corp Has $822,000 Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Earnings Update: Here's Why Analysts Just Lifted Their LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target To US$105 - Simply Wall St
Lemaitre Vascular Inc (LMAT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):